SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-179235
Filing Date
2022-06-23
Accepted
2022-06-23 07:05:56
Documents
16
Period of Report
2022-06-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d318381d8k.htm   iXBRL 8-K 31608
2 EX-10.1 d318381dex101.htm EX-10.1 59092
3 EX-99.1 d318381dex991.htm EX-99.1 10794
7 GRAPHIC g318381g0623080835972.jpg GRAPHIC 2219
8 GRAPHIC g318381g0623082615064.jpg GRAPHIC 2376
  Complete submission text file 0001193125-22-179235.txt   261018

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA vrdn-20220621.xsd EX-101.SCH 2885
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE vrdn-20220621_lab.xml EX-101.LAB 17996
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vrdn-20220621_pre.xml EX-101.PRE 11281
10 EXTRACTED XBRL INSTANCE DOCUMENT d318381d8k_htm.xml XML 3396
Mailing Address 203 CRESCENT STREET BLDG. 17, SUITE 102B WALTHAM MA 02453
Business Address 203 CRESCENT STREET BLDG. 17, SUITE 102B WALTHAM MA 02453 617.272.4600
Viridian Therapeutics, Inc.\DE (Filer) CIK: 0001590750 (see all company filings)

IRS No.: 471187261 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36483 | Film No.: 221033566
SIC: 8071 Services-Medical Laboratories